Fig. 1.

Study design and volunteer disposition. (a) All volunteers who received ≥1 dose of study medication; (b) all volunteers who completed the study with a sufficient number of quantifiable concentrations to warrant parameter estimation in both assessment periods; (c) all volunteers for whom an evaluable PD parameter was obtained in both assessment periods